Gujarat Terce Laboratories Limited Stock Price

BSE:524314 Community·₹355.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

524314 Share Price Performance

₹47.89

-33.32 (-41.03%)

₹47.89

-33.32 (-41.03%)

₹47.89

Mon, 8 Dec 25

Share Pricen/a

524314 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks

1 Reward

View Full Analysis

Gujarat Terce Laboratories Limited Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

n/a

: -1.32
: 61.82%
: -1.95%
: 14.5%

View Full Analysis

About 524314

Founded: 1985
Employees: 244
CEO: Aalap Prajapati
WebsiteView website: www.gujaratterce.in

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.